drugset / Trial / NCT00002946

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

NCT00002946 ↗

Phase 1 Completed 30 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of penclomedine in treating patients with malignant solid tumors or lymphomas. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
1997-10
Primary completion
2002-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject penclomedine Small molecule — Intravenous

Indications